Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma

被引：76

作者：

Rüdiger, T

Gascoyne, RD

Jaffe, ES

de Jong, D

Delabie, J

De Wolf-Peeters, C

Poppema, S

Xerri, L

Gisselbrecht, C

Wiedenmann, S

Müller-Hermelink, HK

机构：

[1] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany

[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

[3] NCI, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA

[4] Netherlands Canc Inst, Amsterdam, Netherlands

[5] Norwegian Radium Hosp, Oslo, Norway

[6] Inst Canc Res, Oslo, Norway

[7] Univ Ziekenhuizen Leuven, Louvain, Belgium

[8] Univ Groningen Hosp, Groningen, Netherlands

[9] Inst J Paoli I Calmettes, F-13009 Marseille, France

[10] Hop St Louis, Paris, France

[11] Univ Cologne, Clin Internal Med 1, Cologne, Germany

来源：

ANNALS OF ONCOLOGY | 2002年 / 13卷

关键词：

D O I：

10.1093/annonc/13.S1.44

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：44 / 51

页数：8

共 23 条

[21] The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis [J].

Straus, SE ;

Jaffe, ES ;

Puck, JM ;

Dale, JK ;

Elkon, KB ;

Rösen-Wolff, A ;

Peters, AMJ ;

Sneller, MC ;

Hallahan, CW ;

Wang, J ;

Fischer, RE ;

Jackson, CM ;

Lin, AY ;

Bäumler, C ;

Siegert, E ;

Marx, A ;

Vaishnaw, AK ;

Grodzicky, T ;

Fleisher, TA ;

Lenardo, MJ .

BLOOD, 2001, 98 (01) :194-200

[22] The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's Disease [J].

Torlakovic, E ;

Tierens, A ;

Dang, HD ;

Delabie, J .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (05) :1807-1814

[23] Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood [J].

van Leeuwen, FE ;

Klokman, WJ ;

van't Veer, MB ;

Hagenbeek, A ;

Krol, ADG ;

Vetter, UAO ;

Schaapveld, M ;

van Heerde, P ;

Burgers, JMV ;

Somers, R ;

Aleman, BMP .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :487-497

← 1 2 3 →